As the rates of obesity and diabetes continue to rise in the United States, so do the rates of complications related to these conditions. Nonalcoholic steatohepatitis (NASH) is one of these complications.

In a new study, researchers argue that the current way for diagnosing kidney failure in patients with cirrhosis is not accurate enough. Their results show that measures used by the Acute Kidney Injury Network (AKIN) may offer more precise results.